CD38 and Miyoshi myopathy: The enhanced susceptibility of CD38lo MM cell lines suggests that combining XmAb24306 with dara may be beneficial if patients have either low expression of CD38 on MM cells as a primary resistance or develop resistance to dara through loss of CD38 expression on MM cells.